In September 2020, the Centers for Medicare & Medicaid Services (CMS) and its Innovation Center (CMMI) finalized the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model. This mandatory payment model will test changes to care for Americans with kidney disease within a 30%, randomized set of Medicare beneficiaries with kidney failure.
The stated goals are increasing patient choice, increasing utilization of home dialysis, and providing greater access to transplantation, options for which the American Society of Nephrology (ASN) has long advocated.
The ETC model is an integral part of federal policy to advance American kidney health, which includes reducing kidney disease progression aimed at reducing kidney disease progression, increasing patient choice and access to transplantation, and increasing innovation in the kidney care space. ASN is dedicated to advocating for improvements and greater support within the model for improved outcomes for patients and nephrologists.
To read the entire ASN Executive Summary: End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model, click here.